Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories-Reference-Cited by-同舟云学术

Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories

Published:2015-02 Issue:1 Volume:13 Page:44-54
ISSN:1540-658X
Container-title:ASSAY and Drug Development Technologies
language:en
Short-container-title:ASSAY and Drug Development Technologies

Author:

Rasmussen Lynn¹²,Tigabu Bersabeh³⁴,White E. Lucile¹²,Bostwick Robert¹²,Tower Nichole¹²,Bukreyev Alexander³⁴⁵,Rockx Barry³⁵⁶,LeDuc James W.³⁴,Noah James W.¹⁷

Affiliation:

1. Drug Discovery Division, Southern Research, Birmingham, Alabama.

2. High Throughput Screening Center, Southern Research, Birmingham, Alabama.

3. Galveston National Laboratory, The University of Texas Medical Branch, Galveston, Texas.

4. Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, Texas.

5. Department of Pathology, The University of Texas Medical Branch, Galveston, Texas.

6. Department of Rare and Emerging Viral Infections and Response (EID), Centre for Infectious Disease Research, Diagnostics and Screening (IDS), National Institute for Public Health and the Environment RIVM, Bilthoven, The Netherlands.

7. Virology Section, Southern Research, Birmingham, Alabama.

Publisher

Mary Ann Liebert Inc

Subject

Drug Discovery,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/adt.2014.617

Reference33 articles.

1. New developments and emerging trends in high-throughput screening methods for lead compound identification

2. Biosafety Guidelines for Handling Microorganisms in the Teaching Laboratory: Development and Rationale

3. Screening methods for influenza antiviral drug discovery

4. Screen for Inducers of Autolysis in Bacillus subtilis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high-throughput response to the SARS-CoV-2 pandemic;SLAS Discovery;2024-07

2. High content screening strategies for large-scale compound libraries with a focus on high-containment viruses;Antiviral Research;2024-01

3. The development and characterization of in vivo-like three-dimensional models of bronchial epithelial cell lines;European Journal of Pharmaceutical Sciences;2023-11

4. Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories;Journal of Virology;2022-02-09

5. SARS-CoV-2 Nucleocapsid Protein TR-FRET Assay Amenable to High Throughput Screening;ACS Pharmacology & Translational Science;2022-01-03